
Benzopyrone represents a privilege scaffold to identify novel adenosine A1/A2A receptor antagonists
Keywords: Benzopyrone; Adenosine A2A receptor; Adenosine A1 receptor; Antagonist; GTP shift; Radioligand binding assay; Cancer; Parkinson's disease; AR; adenosine receptor; GTP; guanosine triphosphate; [3H]DPCPX; [3H]-dipropyl-8-cyclopentylxanthine; [3H]NECA; N-[3H